GlassScriptPhysician profile
Lekhaj Chand Daggubati
NPI 1871987701
$11,109.91
in general payments reported to CMS, 2019-2025
23 companies · $4,824 in 2025
The $4,824 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $180 · 2021: $1,280 · 2022: $273 · 2023: $1,228 · 2024: $2,703 · 2025: $4,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,784 · Travel and Lodging: $3,471 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,783.77 |
| Travel and Lodging | $3,471.06 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,274.00 | 2025 | Other - Miscellaneous |
| Medtronic, INC. | $2,120.07 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Aesculap, INC. | $1,201.84 | 2021 | |
| Monteris Medical Corporation | $832.16 | 2023-2025 | Neuroblate |
| Medtronic USA, INC. | $759.49 | 2019-2020 | |
| Arthrex, INC. | $626.34 | 2024 | Arthrex |
| Omniscient Neurotechnology America LTD | $524.09 | 2023 | Quicktome |
| Boston Scientific Corporation | $442.97 | 2020-2025 | Wavewriter Alpha Prime 16, Infinion 16, Intracept Rf Probe |
| Supreme Orthopedic Systems, LLC | $392.77 | 2024-2025 | |
| Globus Medical, INC. | $306.50 | 2025 | Senza |
| Astrazeneca Pharmaceuticals LP | $237.48 | 2022-2023 | Andexxa |
| Abbott Laboratories | $193.66 | 2024 | Proclaim |
| Livanova USA, INC. | $165.68 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Surgalign Spine Technologies, INC. | $150.76 | 2022 | |
| Kls-Martin L.P. | $147.63 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $142.42 | 2024 | Orgovyx |
| Zimmer Biomet Holdings, INC. | $141.94 | 2023 | Rosa |
| Gt Medical Technologies, INC | $131.14 | 2025 | Gammatile |
| Si-Bone, INC. | $119.78 | 2025 | |
| Integra Lifesciences Corporation | $70.27 | 2023-2024 | Codman Hakim, Codman Certas, Cusa Clarity |
| Theragen, INC. | $45.00 | 2025 | Actastim-S |
| Spine Wave, INC. | $42.56 | 2025 | Spinal Implant |
| Orthofix Medical, INC. | $41.36 | 2024 | Cervical-Stim, Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lekhaj Daggubati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.